Resources

Explore our Resources

Access a curated collection of materials designed to provide insights into our capabilities and expertise across the drug development and manufacturing lifecycle.

Whitepaper

Bioavailability by Design: Lipid Softgel Technology as a Commercial Rescue Path for Poorly Soluble, Low-Bioavailability Molecules

Solubility is broken. The pipeline proves it. What this whitepaper covers: Why solubility failure is the defining challenge of modern oral drug development — and how self-emulsifying softgel technology (SEDDS/SMEDDS/SNEDDS) unlocks bioavailability…

Find out more
Whitepaper

Driving the Shift to Subcutaneous Biologics

The subcutaneous shift has already happened. Is your pipeline ready? In 2000–2004, 25% of FDA biologic approvals were device-based. By 2023-2025, 74% were. OneSource delivers the complete subcutaneous (SC) development stack –…

Find out more
On-Demand Webinar

Accelerating GLP-1 Peptides to Market Through Integrated Formulation & Analytical Development

GLP-1 peptide therapeutics are rapidly reshaping the treatment landscape for diabetes and obesity, increasing the need for robust formulation development and comprehensive analytical characterization strategies that enable safe, scalable, and market-ready drug…

Find out more
Scientific articles

Supply chain resilience is not an insurance cost, but value protection

Supply chain resilience is not an insurance cost, but value protection Anurag Bhagania, Chief Financial Officer Published on BW CFO World, 14 Apr2026 For a long time, the ‘ideal’ supply chain was…

Find out more
Scientific articles

CDMOs as innovation partners in R&D

CDMOs as innovation partners in R&D Prateek Gupta, SVP & head, Technical Development Published on Hindustan Times, 22 Mar 2026 Pharma research and development (R&D) is moving faster and getting harder at…

Find out more

Ready to launch your next breakthrough biologic?

Find out more